Table 1.
Baseline patient, disease, and treatment characteristics for all patients (N = 355)
| Characteristic | Patients, n (%) |
|---|---|
| Age | |
| Median/Range (years) | 60/30-86 |
| Sex | |
| Male | 203 (57.2) |
| Female | 152 (42.8) |
| Race | |
| Black | 150 (42.3) |
| Non-Black | 205 (57.7) |
| ECOG Performance Status | |
| 0 | 165 (46.5) |
| ≥1 | 186 (52.4) |
| Unknown | 4 (1.1) |
| Marital Status | |
| Married | 185 (52.1) |
| Single | 170 (47.9) |
| Smoking | |
| Median/Range (pack-years) | 40/0-212 |
| Charlson Comorbidity Score | |
| ≤6 | 189 (53.2) |
| >6 | 165 (46.5) |
| Unknown | 1 (0.3) |
| Histology | |
| Adenocarcinoma | 117 (33) |
| Squamous Cell | 104 (29.3) |
| NSCLC (NOS) | 111 (31.3) |
| Other | 23 (6.5) |
| T stagea | |
| TX | 18 (5.1) |
| ≤T2 | 161 (45.4) |
| ≥T3 | 174 (49) |
| N stage | |
| NX | 3 (0.8) |
| ≤N1 | 56 (15.8) |
| N2 | 218 (61.4) |
| N3 | 76 (21.4) |
| Stage | |
| IIIA | 200 (56.3) |
| IIIB | 155 (43.7) |
| Mediastinal Staging | |
| PET/CT alone | 99 (27.9) |
| Mediastinoscopy alone | 15 (4.2) |
| EBUS alone | 31 (8.7) |
| PET+Mediastinoscopy | 100 (28.2) |
| EBUS+Mediastinoscopy | 82 (23.2) |
| Other | 28 (7.9) |
| Trimodality vs Bimodality | |
| Trimodality | 88 (24.8) |
| Unplanned bimodalityb | 89 (25.1) |
| Planned Bimodality | 178 (50.1) |
| Type of Surgery | |
| Lobectomy | 76 (86.4) |
| Pneumonectomy | 12 (13.6) |
| Type of Chemoradiation | |
| Concurrent | 327 (92.1) |
| Sequential | 28 (7.9) |
| Prescribed Radiation Dosec | |
| Median/Range (Gy) | 64.8/45-81.6 |
| Radiation Dose Deliveredc | |
| >60 Gy | 293 (83) |
| Radiation Techniqued | |
| 3-dimensional conformal | 235 (66.2) |
| IMRT | 84 (23.7) |
| Adjuvant Chemotherapye | |
| Yes | 212 (69.7) |
CT, computed tomography; EBUS, endobronchial ultrasound; ECOG, Eastern Cooperative Oncology Group; IMRT, intensity modulated radiation therapy; NSCLC (NOS), non-small cell lung cancer (not otherwise specified); PET, positron emission tomography.
a
T and N stage are not known for 2 patients.
b
Unplanned bimodality comprised patients who were initially planned for surgery after definitive chemoradiation but ultimately did not receive any surgical treatment.
c
Data are not available for 11 patients.
d
Data are not available for 36 patients.
e
Data are not available for 51 patients.